nasopharyngeal cancer

Showing 1 - 25 of 49

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Tumors Trial in Germany (drug, radiation, procedure, behavioral)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Aachen, Germany
  • +28 more
Aug 24, 2023

Gut Microbiota of Critical Chronic Diseases in China

Recruiting
  • Essential Hypertension
  • +10 more
  • no intervention
  • Chaoyang, Beijing, China
  • +49 more
Dec 16, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Cancer
  • Bengbu, Anhui, China
  • +12 more
Dec 13, 2022

Intrinsic Radiation Sensitivity in Cancer Patients

Recruiting
  • Nasopharyngeal Cancer
  • +2 more
    • Singapore, Singapore
      National Cancer Center Singapore
    Dec 1, 2022

    Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)

    Recruiting
    • Nasopharyngeal Cancer
    • Toripalimab
    • Induction chemotherapy and concurrent chemoradiation
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Nov 25, 2022

    Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T

    Recruiting
    • Breast Cancer
    • +8 more
    • San Francisco, California
    • +4 more
    Oct 26, 2022

    Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

    Recruiting
    • Nasopharyngeal Cancer
    • Epstein-Barr Virus Related Carcinoma
    • FDG-PET
    • Galium-68 DOTATATE
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 13, 2022

    Cervical Cancer, Nasopharyngeal Cancer, Chemo-induced Nausea and Vomiting Trial in Shantou (Fosaprepitant, tropisetron,

    Recruiting
    • Cervical Cancer
    • +4 more
    • Shantou, Guangdong, China
      Cancer Hospital of Shantou University Medical College
    Sep 29, 2022

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in Shanghai (Fluzoparib and Camrelizumab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Nasopharyngeal Cancer
    • Fluzoparib and Camrelizumab
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Jun 4, 2022

    Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)

    Recruiting
    • Nasopharyngeal Cancer
    • Epstein-Barr Virus Related Carcinoma
    • Stanford, California
      Stanford University
    Mar 31, 2022

    Nasopharyngeal Cancer Trial in Singapore (cisplatin and gemcitabine, induction chemo cisplatin, gemcitabine, bevacizumab and

    Not yet recruiting
    • Nasopharyngeal Cancer
    • cisplatin and gemcitabine
    • induction chemotherapy cisplatin, gemcitabine, bevacizumab and pembrolizumab.
    • Singapore, Singapore
      National University Hospital
    Mar 22, 2022

    Nasopharyngeal Cancer Trial in Jakarta (Auto-Dendritic Adjuvant Therapy, Allo-Dendritic-Secretome Adjuvant Therapy)

    Not yet recruiting
    • Nasopharyngeal Cancer
    • Auto-Dendritic Adjuvant Therapy
    • Allo-Dendritic-Secretome Adjuvant Therapy
    • Jakarta, Indonesia
      PT Prodia StemCell Indonesia
    Mar 1, 2022

    Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

    Recruiting
    • Pancreatic Cancer
    • +49 more
      • Colorado Springs, Colorado
      • +80 more
      Feb 22, 2022

      Nasopharyngeal Cancer Trial in Hong Kong (Adjuvant chemo (gemcitabine and cisplatin))

      Completed
      • Nasopharyngeal Cancer
      • Adjuvant chemotherapy (gemcitabine and cisplatin)
      • Hong Kong, Hong Kong
      • +5 more
      Feb 15, 2022

      Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Copenhagen (Liquid biopsy)

      Recruiting
      • Head and Neck Cancer
      • +26 more
      • Liquid biopsy
      • Copenhagen, Region Hovedstaden, Denmark
        University Hospital of Copenhagen, Rigshospitalet
      Sep 14, 2021

      Nasopharyngeal Cancer, Epstein-Barr Virus Infections Trial in Hong Kong (Recombinant Epstein-Barr Virus (EBV) Vaccine)

      Completed
      • Nasopharyngeal Cancer
      • Epstein-Barr Virus Infections
      • Recombinant Epstein-Barr Virus (EBV) Vaccine
      • Hong Kong, Hong Kong
        Department of Clinical Oncology, Prince of Wales Hospital
      Jul 26, 2021

      Nasopharyngeal Cancer Trial in Poland (Opdivo)

      Not yet recruiting
      • Nasopharyngeal Cancer
      • Białystok, Poland
      • +3 more
      Jun 21, 2021

      Xerostomia, Mouth Dryness, Nasopharyngeal Cancer Trial in Shanghai (Acupuncture, Standard Care)

      Completed
      • Xerostomia
      • +2 more
      • Acupuncture
      • Standard Care
      • Shanghai, China
        Fudan University Cancer Hospital
      Jun 8, 2021

      Nasopharyngeal Cancer Trial in Guangzhou (Nab paclitaxel)

      Recruiting
      • Nasopharyngeal Cancer
      • Nab paclitaxel
      • Guangzhou, Guangdong, China
        Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
      Apr 22, 2021

      Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI

      Completed
      • Nasopharyngeal Cancer
      • PET/CT scans
      • New York, New York
        New York University School of Medicine
      Oct 15, 2020

      Nasopharyngeal Cancer, Chemo, Radiotherapy Trial in China (Camrelizumab plus chemo-radiotherapy, Chemo-radiotherapy alone)

      Recruiting
      • Nasopharyngeal Cancer
      • +3 more
      • Camrelizumab plus chemo-radiotherapy
      • Chemo-radiotherapy alone
      • Guangzhou, Guangdong, China
      • +5 more
      Sep 24, 2020

      Nasopharyngeal Cancer, Tumor Metastasis Trial in Hangzhou (radical radiotherapy)

      Recruiting
      • Nasopharyngeal Cancer
      • Neoplasm Metastasis
      • radical radiotherapy
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Sep 16, 2020

      Liver Cancer, Kidney Cancer, Nasopharyngeal Cancer Trial in Guangzhou (CELL)

      Recruiting
      • Liver Cancer
      • +5 more
      • CELL
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jul 14, 2020

      Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Esophageal Cancer Trial in Belgium, United States (INCB062079)

      Terminated
      • Hepatocellular Carcinoma (HCC)
      • +5 more
      • Birmingham, Alabama
      • +5 more
      Jul 13, 2020